Shanghai Pharmaceuticals Holding Co., Ltd
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
3/10
|
48.42 | 31.39 | 54.25% | 14.64 | +230.7% |
| P/S |
|
0.703 | 3.24 | -78.33% |
|
|
| P/BV |
|
0.3177 | 3.11 | -89.77% |
|
|
| P/FCF |
|
21.17 | 16.62 | 27.4% |
|
|
| Ev/Ebitda |
|
36.85 | 10.15 | 262.92% |
|
|
| Ev/S |
|
1.5 | 1.92 | -22.03% |
|
|
| Ev/FCF |
|
119.91 | 13.61 | 781.04% |
|
|
| E/P |
|
0.0549 | 1.47 | -96.27% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
1/10
|
4.07 | 25 | -83.73% | 4.6 | -11.55% |
| ROE |
|
0.7745 | 13.27 | -94.16% |
|
|
| ROA |
|
0.2504 | 6.22 | -95.98% |
|
|
| ROIC |
|
0 | 15.56 | -100% |
|
|
| ROS |
|
1.45 | 12.78 | -88.65% |
|
|
| ROCE |
|
1.43 | 12.36 | -88.43% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
38.34 | 6.27 | 511.1% | 22.24 | +72.41% |
| Nеt Debt/Ebitda |
|
19.56 | -5.75 | -439.99% |
|
|
| Debt/Ratio |
|
0.2689 | 0.2158 | 24.61% |
|
|
| Debt/Equity |
|
2.77 | 3.24 | -14.35% |
|
|
| Debt/Net Income |
|
107.41 | 15.22 | 605.58% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
9.48/10
|
3.79 | 1.53 | 147.31% | 4.09 | -7.35% |
| Number of years of dividend growth |
|
0 | 1.3 | -100% | ||
| DSI |
|
0.8571 | 0.7874 | 8.86% |
|
|
| Average dividend growth |
|
4.3 | -247.1 | -101.74% |
|
|
| Average percentage for 5 years |
|
4.09 | 2.81 | 45.75% |
|
|
| Average percentage for payments |
|
102.56 | 245.62 | -58.24% |
|
|
| Difference from average difference in sector |
|
2.26 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-80.24 | 53.19 | -250.86% | ||
| Growth impulse Ebitda in 5 years |
|
-83.8 | 39.91 | -309.97% | ||
| Growth impulse Net Income in 5 years |
|
-86.93 | 46.39 | -287.39% | ||
| Growth impulse FCF in 5 years |
|
-90.21 | 26.84 | -436.1% | ||
| Growth impulse EPS in 5 years |
|
-89.94 | 106.95 | -184.1% |
IP Score
3.63/10
